As announced on September 13, InMed has signed a definitive agreement to acquire BayMedica, a leading commercial manufacturer of rare cannabinoids.
InMed and BayMedica invite you to join a webinar to learn more about this transaction and to hear about InMed’s future developments.
Join InMed’s CEO, Eric A. Adams, and BayMedica’s co-founder, Shane Johnson, for the webinar, hosted by Edison Research, on Thursday September 16, 2021 at 11:00 am ET.
Watch a replay of the webinar here.
